Evercore ISI raised the firm’s price target on Healthpeak Properties to $25 from $24 and keeps an Outperform rating on the shares. While the magnitude of future Fed rate cuts remains open to debate, as does the pace of job growth and the ultimate impact on GDP growth, it is “clear that the interest rate path is one that is more favorable for the CRE space and REITs overall,” contends the analyst while “tweaking” valuation inputs for the firm’s REIT coverage ahead of the upcoming Fed easing cycle.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOC:
- Healthpeak Properties price target raised to $22 from $20 at Citi
- Healthpeak Properties price target raised to $25 from $22 at RBC Capital
- Healthpeak Properties Publishes Mid-Year Financial Insights
- Healthpeak Properties raises FY24 FFO view to $1.77-$1.81
- Healthpeak Properties reports Q2 AFFO 39c, consensus 44c